Home » Stocks » Helius Medical Technologies

Helius Medical Technologies, Inc. (HSDT)

Stock Price: $0.449 USD -0.013 (-2.71%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $0.461 +0.011 (2.49%) Oct 21, 7:50 PM

Stock Price Chart

Key Info

Market Cap 20.27M
Revenue (ttm) 642,000
Net Income (ttm) -19.04M
Shares Out 45.11M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $0.449
Previous Close $0.462
Change ($) -0.013
Change (%) -2.71%
Day's Open 0.470
Day's Range 0.440 - 0.470
Day's Volume 135,964
52-Week Range 0.249 - 1.690

More Stats

Market Cap 20.27M
Enterprise Value 15.22M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 45.11M
Float 36.13M
EPS (basic) -0.65
EPS (diluted) -0.60
FCF / Share -0.42
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 960,702
Short Ratio 5.41
Short % of Float 2.66%
Beta 0.75
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 31.57
PB Ratio 3.03
Revenue 642,000
Operating Income -19.09M
Net Income -19.04M
Free Cash Flow -16.86M
Net Cash 5.05M
Net Cash / Share 0.11
Gross Margin 101.56%
Operating Margin -2,972.74%
Profit Margin -2,965.30%
FCF Margin -2,626.48%
ROA -87.38%
ROE -198.53%
ROIC -4,056.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

Current: $0.449
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth212.97%-----
Gross Profit0.650.48----
Operating Income-24.00-26.68-22.85-9.32-9.81-1.07
Net Income-9.78-28.62-28.02-6.88-9.84-1.07
Shares Outstanding26.3522.7918.6313.3011.416.41
Earnings Per Share-0.37-1.26-1.50-0.60-0.85-0.15
Operating Cash Flow-21.00-19.62-19.33-7.94-6.32-0.35
Capital Expenditures-0.35-0.44-0.19---
Free Cash Flow-21.35-20.06-19.52-7.94-6.32-0.35
Cash & Equivalents5.4625.585.562.640.800.02
Total Debt0.64----0.37
Net Cash / Debt4.8225.585.562.640.80-0.35
Book Value5.849.85-7.49-0.02-1.56-0.27
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Helius Medical Technologies, Inc.
Country United States
Employees 19
CEO Dane Carl Andreeff

Stock Information

Ticker Symbol HSDT
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: HSDT


Helius Medical Technologies, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.